{"id":4284,"date":"2023-04-14T09:00:19","date_gmt":"2023-04-14T09:00:19","guid":{"rendered":"https:\/\/ubc.com\/?p=4284"},"modified":"2025-05-15T19:29:40","modified_gmt":"2025-05-15T19:29:40","slug":"current-safety-regulations-clinical-development","status":"publish","type":"insights","link":"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/","title":{"rendered":"Evaluating Existing Safety Surveillance Regulations for Drug Development"},"content":{"rendered":"<p>UBC is proud to announce the publication of members of our pharmacovigilance team in Advances in Therapy. The article &#8211; &#8220;Safety Surveillance During Drug Development: Comparative Evaluation of Existing Regulations&#8221; &#8211; features contributions from Safety Scientists Christopher Henry, Alix Garcia, Chysanthi Samara, Safety Physician Laure Valotton, and Pharmacovigilance Physician Leader Alexis Pincon.<\/p>\n<p>Safety surveillance during drug development is a globally recognized necessity. However, different regions and countries have different standards for what is required, leading to safety processes that need to be harmonized. This research analyzes the current regulations and seeks out solutions to increase the global viability of safety surveillance during drug development.<\/p>\n<p>To read the full paper, click <a href=\"https:\/\/link.springer.com\/epdf\/10.1007\/s12325-023-02492-3?sharing_token=_LrbAXpMFF8abRTRstQRvfe4RwlQNchNByi7wbcMAY4HjrZ4GvnOYxvnMBzk2SlQ8x6BbA3PeMAn0V_Kr8k5uf18nzXJ-zuM-Ac3_BUVuZTfWUf1aCp4kCeezGvrgmzyCxt9Xn6DCXT13IZQT-_BEOBqM0G97FGZ-9ckq9XcZEc=\" target=\"_blank\" rel=\"noopener\">here<\/a>.<\/p>\n<p>UBC\u2019s pharmacovigilance team excels at handling every aspect of your safety requirements at all stages of the drug lifecycle. Our commitment to Patients First has driven us to balance high-tech solutions with a personalized, experienced touch in our services. To learn more about UBC&#8217;s physician-driven pharmacovigilance offering, click <a href=\"\/solution\/safety-risk-management\/pharmacovigilance\/\">here<\/a>. To contact our team directly, click <a href=\"https:\/\/ubc.com\/contact-us\/\">here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>UBC&#8217;s pharmacovigilance experts compare current safety regulations in Advances in Therapy.<\/p>\n","protected":false},"featured_media":10615,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"insights_category":[35],"insights_tags":[],"class_list":["post-4284","insights","type-insights","status-publish","format-standard","has-post-thumbnail","hentry","insights_category-articles"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.7 (Yoast SEO v26.1.1) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Current Safety Regulations in Clinical Development - UBC<\/title>\n<meta name=\"description\" content=\"Read this published article from UBC&#039;s pharmacovigilance experts comparing current safety regulations in Advances in Therapy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evaluating Existing Safety Surveillance Regulations for Drug Development\" \/>\n<meta property=\"og:description\" content=\"Read this published article from UBC&#039;s pharmacovigilance experts comparing current safety regulations in Advances in Therapy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/\" \/>\n<meta property=\"og:site_name\" content=\"UBC\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-15T19:29:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ubc.com\/wp-content\/uploads\/2019\/04\/EBV-2.0-PR-1275x1080-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1275\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/\",\"url\":\"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/\",\"name\":\"Current Safety Regulations in Clinical Development - UBC\",\"isPartOf\":{\"@id\":\"https:\/\/ubc.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ubc.com\/wp-content\/uploads\/2019\/04\/EBV-2.0-PR-1275x1080-1.png\",\"datePublished\":\"2023-04-14T09:00:19+00:00\",\"dateModified\":\"2025-05-15T19:29:40+00:00\",\"description\":\"Read this published article from UBC's pharmacovigilance experts comparing current safety regulations in Advances in Therapy.\",\"breadcrumb\":{\"@id\":\"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/#primaryimage\",\"url\":\"https:\/\/ubc.com\/wp-content\/uploads\/2019\/04\/EBV-2.0-PR-1275x1080-1.png\",\"contentUrl\":\"https:\/\/ubc.com\/wp-content\/uploads\/2019\/04\/EBV-2.0-PR-1275x1080-1.png\",\"width\":1275,\"height\":1080,\"caption\":\"Man touching screen with his finger and AI robot touching the screen from the other side of the device.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ubc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insights\",\"item\":\"https:\/\/ubc.com\/insights\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Evaluating Existing Safety Surveillance Regulations for Drug Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ubc.com\/#website\",\"url\":\"https:\/\/ubc.com\/\",\"name\":\"UBC\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/ubc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ubc.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ubc.com\/#organization\",\"name\":\"UBC\",\"url\":\"https:\/\/ubc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ubc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ubc.com\/wp-content\/uploads\/2023\/07\/Layer_1.png\",\"contentUrl\":\"https:\/\/ubc.com\/wp-content\/uploads\/2023\/07\/Layer_1.png\",\"width\":188,\"height\":50,\"caption\":\"UBC\"},\"image\":{\"@id\":\"https:\/\/ubc.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Current Safety Regulations in Clinical Development - UBC","description":"Read this published article from UBC's pharmacovigilance experts comparing current safety regulations in Advances in Therapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/","og_locale":"en_US","og_type":"article","og_title":"Evaluating Existing Safety Surveillance Regulations for Drug Development","og_description":"Read this published article from UBC's pharmacovigilance experts comparing current safety regulations in Advances in Therapy.","og_url":"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/","og_site_name":"UBC","article_modified_time":"2025-05-15T19:29:40+00:00","og_image":[{"width":1275,"height":1080,"url":"https:\/\/ubc.com\/wp-content\/uploads\/2019\/04\/EBV-2.0-PR-1275x1080-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/","url":"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/","name":"Current Safety Regulations in Clinical Development - UBC","isPartOf":{"@id":"https:\/\/ubc.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/#primaryimage"},"image":{"@id":"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/#primaryimage"},"thumbnailUrl":"https:\/\/ubc.com\/wp-content\/uploads\/2019\/04\/EBV-2.0-PR-1275x1080-1.png","datePublished":"2023-04-14T09:00:19+00:00","dateModified":"2025-05-15T19:29:40+00:00","description":"Read this published article from UBC's pharmacovigilance experts comparing current safety regulations in Advances in Therapy.","breadcrumb":{"@id":"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/#primaryimage","url":"https:\/\/ubc.com\/wp-content\/uploads\/2019\/04\/EBV-2.0-PR-1275x1080-1.png","contentUrl":"https:\/\/ubc.com\/wp-content\/uploads\/2019\/04\/EBV-2.0-PR-1275x1080-1.png","width":1275,"height":1080,"caption":"Man touching screen with his finger and AI robot touching the screen from the other side of the device."},{"@type":"BreadcrumbList","@id":"https:\/\/ubc.com\/insights\/current-safety-regulations-clinical-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ubc.com\/"},{"@type":"ListItem","position":2,"name":"Insights","item":"https:\/\/ubc.com\/insights\/"},{"@type":"ListItem","position":3,"name":"Evaluating Existing Safety Surveillance Regulations for Drug Development"}]},{"@type":"WebSite","@id":"https:\/\/ubc.com\/#website","url":"https:\/\/ubc.com\/","name":"UBC","description":"","publisher":{"@id":"https:\/\/ubc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ubc.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ubc.com\/#organization","name":"UBC","url":"https:\/\/ubc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ubc.com\/#\/schema\/logo\/image\/","url":"https:\/\/ubc.com\/wp-content\/uploads\/2023\/07\/Layer_1.png","contentUrl":"https:\/\/ubc.com\/wp-content\/uploads\/2023\/07\/Layer_1.png","width":188,"height":50,"caption":"UBC"},"image":{"@id":"https:\/\/ubc.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/insights\/4284","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/insights"}],"about":[{"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/types\/insights"}],"replies":[{"embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/comments?post=4284"}],"version-history":[{"count":3,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/insights\/4284\/revisions"}],"predecessor-version":[{"id":12769,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/insights\/4284\/revisions\/12769"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/media\/10615"}],"wp:attachment":[{"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/media?parent=4284"}],"wp:term":[{"taxonomy":"insights_category","embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/insights_category?post=4284"},{"taxonomy":"insights_tags","embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/insights_tags?post=4284"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}